Trials / Completed
CompletedNCT06181604
Multicenter Symphony IL-6 Monitoring Sepsis ICU Study
Multicenter Symphony IL-6 Monitoring Sepsis ICU Pilot Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 143 (actual)
- Sponsor
- Bluejay Diagnostics, Inc. · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to establish an IL-6 concentration cutoff and optimal time point(s) for using Symphony IL-6 that predict 28-day mortality in patients who are admitted or are intended to be admitted to the intensive care unit (ICU) diagnosed with sepsis or septic shock.
Conditions
Timeline
- Start date
- 2024-01-12
- Primary completion
- 2024-07-12
- Completion
- 2024-07-12
- First posted
- 2023-12-26
- Last updated
- 2025-08-03
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06181604. Inclusion in this directory is not an endorsement.